Paclitaxel in the Treatment of Carcinosarcoma of the Uterus: A Gynecologic Oncology Group Study

This publication has 7 references indexed in Scilit:

• A Phase III Trial of Ifosfamide with or without Cisplatin in Carcinosarcoma of the Uterus: A Gynecologic Oncology Group Study
  Gynecologic Oncology, 2000
• Phase II Trial of Hydroxyurea, Dacarbazine (DTIC), and Etoposide (VP-16) in Mixed Mesodermal Tumors of the Uterus: A Gynecologic Oncology Group Study
  Gynecologic Oncology, 1996
• European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: high-dose versus low-dose and long versus short infusion.
  Journal of Clinical Oncology, 1994
• A Phase II Trial of Ifosfamide and Mesna in Patients with Advanced or Recurrent Mixed Mesodermal Tumors of the Ovary Previously Treated with Platinum-Based Chemotherapy: A Gynecologic Oncology Group Study
  Gynecologic Oncology, 1994
• Phase II trial of ifosfamide and mesna in mixed mesodermal tumors of the uterus (A Gynecologic Oncology Group Study)
  American Journal of Obstetrics and Gynecology, 1989
• Observations on the use of adjuvant radiation therapy in patients with stage I and II uterine sarcoma
  International Journal of Radiation Oncology*Biology*Physics, 1986
• A randomized study of adriamycin with and without dimethyl triazenoimidazole carboxamide in advanced uterine sarcomas
  Cancer, 1983